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Background
Juvenile dermatomyositis (JDM) patients may present
many risk factors for dyslipidemia such as chronic
inflammation and corticosteroid therapy. To our knowl-
edge, the concomitant evaluation of lipid profile, anti-
lipoprotein lipase antibody (anti-LPL), clinical and
laboratory assessments, and treatment have not been
performed.
Aim
To evaluate dyslipidemia in JDM patients and healthy
controls.
Methods
25 JDM patients followed at the Pediatric Rheumatology
Unit of our tertiary University Hospital were compared
to 25 healthy controls according to demographic data,
fasting lipoproteins, glycemia and insulin, anti-LPL anti-
bodies and muscle enzymes. All patients were evaluated
by the same pediatric rheumatologist in order to evalu-
ate the following JDM scores: Disease Activity Score
(DAS), Childhood Myositis Assessment Scale(CMAS),
Manual Muscle Testing(MMT), Myositis Disease Activ-
ity Assessment Analogue Scale(MYOACT) and Myositis
Intention To Treat Activity Index (MYTAX).
Results
The mean current age of JDM was similar to controls
(138.6±45.96 vs. 134±31 months, p=0.7), likewise the
female gender (56% vs. 52%, p=0.5). Abnormal lipid
profile was observed in 9 patients(36%) and 4(16%)
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levels were found in seven(28%), high triglycerides in
four (TG)(16%), high total cholesterol in three(12%)
and high LDL in one(4%). Lipodystrophy was observed
in only one JDM patients with dyslipidemia. JDM
patients presented higher levels of VLDL (16vs.13mg/
dl,p=0.02), triglycerides (80vs.61mg/dl,p=0.011), fast
insulin (8vs.3.9µU/ml,p=0.01), and lower glucose/insu-
lin rate (8.8vs.19.7,p=0.004) compared to controls. JDM
with dyslipidemia had higher AST levels(32 vs 24,5U/L,
p=0,044), ESR(26vs14.5mm/1
st hour,p=0.006) and CRP
(2.1vs0.4mg/dl,p=0.006) compared with patients with
normal lipid profile. In addition, this group also had
higher scores of DAS(6vs.2,p=0.008), MYOACT
(0.13vs.0.01,p=0.012), MYTAX(0.06vs.0,p=0.018), and
lower scores of CMAS(47vs.52,p=0.024) and MMT
(78vs.80,p=0.001) compared to JDM without dyslipide-
mia. Positive correlations were detected between TG
levels and CRP(r=0.697,p=0.001), DAS(r=0.610,
p=0.001), MYOACT(r=0.661,p=0.001), MYTAX
(r=0.511,p=0.008), and negative correlations between
TG and CMAS(r=-0.506,p=0.009) and MMT(r=-0.535,
p=0.005). Furthermore, positive correlations were
found between LDL and DAS(r=0.425,p=0,034),
MYOACT(r=0.534,p=0,006), MYTAX (r=0.415,
p=0.039) and negative correlation with CMAS(r=-0.48,
p=0,0248). However, no differences were found
between JDM with and without dyslipidemia regarding
body mass index, lipodystrophy, anti-LPL antibodies,
and treatment (current and cumulative doses of pre-
dnisone, methotrexate and cyclosporine) (p>0.05).
Conclusions
Dyslipidemia was observed in active JDM patients, sug-
gesting that adequate disease control and individualized
use of lipid-lowering agents may lower the risk of pre-
mature atherosclerosis in these patients.
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